oral glp 1 GLP-1 Liquid Therapy for Metabolic & Weight Health Lilly's Oral GLP-1 Foundayo Outperforms

Because prospective endpoint studies comprising large patient populations had just been published for saxagliptin (The Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus [SAVOR]Thrombolysis in Myocardial Infarction [TIMI] 53 trial [SAVOR-TIMI 53]

Mechanisms and potential targets of GLP-1RAs Neuroprotective effects The established anti-inflammatory and neuroprotective effects of GLP-1RAs within the central nervous system suggest their therapeutic potential across a spectrum of neurodegenerative disorders [40, 41]

A population-based matched case (220) controlled study found that the treatment of patient with T2MD with exenatide might increase the chance of hospitalization for acute pancreatitis

Anti-inflammatory and glial effects In preclinical models, GLP-1R activation suppresses microglial activation and lowers central production of TNF-alpha, IL-1 beta, and IL-6

Their effects often emerge only in specific physiological contexts, such as exercise, growth, or aging, and may depend on coordinated signaling across multiple tissues